Newron Pharmaceuticals Spa Stock Forecast

Sell candidate since Jul 03, 2026

The Newron Pharmaceuticals Spa stock price fell by -4.32% on the last day (Friday, 3rd Jul 2026) from 13.90€ to 13.30€. During the last trading day the stock fluctuated 2.26% from a day low at 13.25€ to a day high of 13.55€. The price has been going up and down for this period, and there has been a 0.38% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 3 thousand shares were bought and sold for approximately 38.17€ thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.36% during the next 3 months and, with a 90% probability hold a price between 8.65€ and 10.52€ at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NP5.DE Signals & Forecast

There are mixed signals in the stock today. The Newron Pharmaceuticals Spa stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 13.72€ and 14.07€. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 3.10%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Newron Pharmaceuticals Spa stock

Newron Pharmaceuticals Spa finds support from accumulated volume at 13.20€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved 0.300€ between high and low, or 2.26%. For the last week the stock has had daily average volatility of 2.80%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NP5.DE) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Newron Pharmaceuticals Spa to open at 13.37€, and during the day (based on 14 day Average True Range), to move between 13.02€ and 13.58€, which gives a possible trading interval of +/-0.554€ (+/-4.25%) up or down from last closing price. If Newron Pharmaceuticals Spa takes out the full calculated possible swing range there will be an estimated 4.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 13.20€ (0.75%) than the resistance at 15.40€ (15.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Newron Pharmaceuticals Spa stock A Buy?

Newron Pharmaceuticals Spa holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.992 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - 13.37€ ( 0.501%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk